318 related articles for article (PubMed ID: 36980536)
1. Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy.
Andreu-Sanz D; Kobold S
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980536
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and Regulation of T
Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
Front Immunol; 2021; 12():669474. PubMed ID: 34012451
[TBL] [Abstract][Full Text] [Related]
3. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
4. Helper-independent, L-selectinlow CD8+ T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression.
Peng L; Kjaergaard J; Plautz GE; Weng DE; Shu S; Cohen PA
J Immunol; 2000 Nov; 165(10):5738-49. PubMed ID: 11067932
[TBL] [Abstract][Full Text] [Related]
5. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
6. Low-dose total body irradiation facilitates antitumoral Th1 immune responses.
Sonanini D; Griessinger CM; Schörg BF; Knopf P; Dittmann K; Röcken M; Pichler BJ; Kneilling M
Theranostics; 2021; 11(16):7700-7714. PubMed ID: 34335959
[TBL] [Abstract][Full Text] [Related]
7. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
8. Helper-like innate lymphoid cells and cancer immunotherapy.
Crinier A; Vivier E; Bléry M
Semin Immunol; 2019 Feb; 41():101274. PubMed ID: 31072659
[TBL] [Abstract][Full Text] [Related]
9. Role of memory T cell subsets for adoptive immunotherapy.
Busch DH; Fräßle SP; Sommermeyer D; Buchholz VR; Riddell SR
Semin Immunol; 2016 Feb; 28(1):28-34. PubMed ID: 26976826
[TBL] [Abstract][Full Text] [Related]
10. Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer.
Saillard M; Cenerenti M; Romero P; Jandus C
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34064410
[TBL] [Abstract][Full Text] [Related]
11. Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy.
Golubovskaya V; Wu L
Cancers (Basel); 2016 Mar; 8(3):. PubMed ID: 26999211
[TBL] [Abstract][Full Text] [Related]
12. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
13. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
14. Harnessing Antitumor CD4
Ben Khelil M; Godet Y; Abdeljaoued S; Borg C; Adotévi O; Loyon R
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008422
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.
Wang LX; Shu S; Disis ML; Plautz GE
Blood; 2007 Jun; 109(11):4865-76. PubMed ID: 17284532
[TBL] [Abstract][Full Text] [Related]
16. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.
Kenway-Lynch CS; Das A; Lackner AA; Pahar B
J Virol; 2014 Aug; 88(16):9442-57. PubMed ID: 24920807
[TBL] [Abstract][Full Text] [Related]
17. Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling Pathways and CD4
Powell MD; Read KA; Sreekumar BK; Oestreich KJ
Front Immunol; 2019; 10():1299. PubMed ID: 31244845
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the role of CD4
Tay RE; Richardson EK; Toh HC
Cancer Gene Ther; 2021 Feb; 28(1-2):5-17. PubMed ID: 32457487
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
20. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review.
Bao Y; Cao X
J Autoimmun; 2014 Dec; 55():10-23. PubMed ID: 24794622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
